Chabio
1 known investors
Matika Bio develops cell and gene therapies to treat rare cancers and intractable diseases. The company operates as a global biopharmaceutical firm with capabilities in personalized cell therapy development and viral vector technologies.
BiotechHealthtechMedical Devices
Investors · 1
Frequently asked questions
- What does Chabio do?
- Matika Bio develops cell and gene therapies to treat rare cancers and intractable diseases. The company operates as a global biopharmaceutical firm with capabilities in personalized cell therapy development and viral vector technologies.
- Who are Chabio's investors?
- Chabio's investors include Kiwoom Investment.